<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>http://elea.unisa.it/xmlui/handle/10556/519</link>
    <description />
    <pubDate>Mon, 20 Apr 2026 15:24:10 GMT</pubDate>
    <dc:date>2026-04-20T15:24:10Z</dc:date>
    <item>
      <title>Letter to the editor: The Use of Organs from Executed Prisoners in China</title>
      <link>http://elea.unisa.it/xmlui/handle/10556/630</link>
      <description>Title: Letter to the editor: The Use of Organs from Executed Prisoners in China
Authors: Romano, Rosalba; Piazza, Ornella</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://elea.unisa.it/xmlui/handle/10556/630</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Exercise training in aging and diseases</title>
      <link>http://elea.unisa.it/xmlui/handle/10556/629</link>
      <description>Title: Exercise training in aging and diseases
Authors: Conti, Valeria; Russomanno, Giusy; Corbi, Graziamaria; Filippelli, Amelia
Abstract: Sedentary lifestyle along with high blood pressure,
abnormal values for blood lipids, smoking, and obesity
are recognized risk factors for cardiovascular diseases and
for many other chronic diseases, such as diabetes,
osteoporosis, breast and colon cancer. Several studies
conducted on large cohort of individuals have
documented the protective effects of physical activity for
both vascular and nonvascular syndromes.
Exercise training is an integral part of cardiac
rehabilitation, a complex therapeutic approach, effective
both in young and elderly patients. Despite the number of
evidences underling the benefits associated with physical
fitness, the cardiac rehabilitation is still an underused
medical resource.
The molecular mechanism behind physical activity
protective effect is presently unresolved, and further
studies are also needed to establish the best protocol in
terms of specificity, volume and duration of the training.</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://elea.unisa.it/xmlui/handle/10556/629</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Posttranscriptional gene regulation: novel pathways for glucocorticoids? Anti-inflammatory action</title>
      <link>http://elea.unisa.it/xmlui/handle/10556/628</link>
      <description>Title: Posttranscriptional gene regulation: novel pathways for glucocorticoids? Anti-inflammatory action
Authors: Stellato, Cristiana
Abstract: Posttranscriptional gene regulation 
(PTR) is a fundamental biological process that 
integrates with the master transcriptional control of 
gene expression, in ways that only in the last decade 
have been increasingly understood [1, 2]. While 
epigenetic and transcriptional events shape cell 
response qualitatively, deciding the pattern of gene 
expression to ‘switch on or off’ in response to 
endogenous or environmental triggers, the key task of 
PTR is to act as a ‘rheostat’ and rapidly adapt the 
cellular response by providing the appropriate 
amplitude and timing to the protein expression patterns 
[3, 4]. The pivotal role of this mechanism comes to the 
forefront in inflammatory and immune response, where 
the changes in amplitude and duration in the expression 
of dangerous and protective genes are in delicate 
balance, and are critical in determining either the 
successful resolution of the immune response or its 
chronic overexpression [5]. This brief review introduces 
members of the main classes of molecules mediating the 
cytoplasmic arm of gene regulation, namely RNAbinding proteins and micro-RNA (miRNA), and 
summarizes experimental data that underscore the role 
of these molecules in the pathophysiology of chronic 
inflammation, as well as their promising value as 
mechanisms conveying the anti-inflammatory effect of 
synthetic glucocorticoids.</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://elea.unisa.it/xmlui/handle/10556/628</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Breakthrough pain: the importance of baseline analgesic regimen with opioids</title>
      <link>http://elea.unisa.it/xmlui/handle/10556/627</link>
      <description>Title: Breakthrough pain: the importance of baseline analgesic regimen with opioids
Authors: Zampi, Maddalena; Morabito, Antonietta; Salvato, Fabiana; Vinciguerra, Annamaria
Abstract: Pain is one of the most common and often most
feared symptoms in patients with cancer. Ongoing or
progressive pain is physically debilitating and has a
marked impact on quality of life. During their illness, at
least 70% of patients will experience pain sufficiently
severe to require chronic opioid treatment. Moreover,
Breakthrough Pain (BTP) consists in transitory
exacerbations of pain that occurs on a background of
otherwise stable pain in a patient receiving chronic opioid
therapy. An inadequate baseline therapy with opioids can
be one of the causes of BTP.
We will examine the molecular issues that influence the
response of patients to opioids. Finally, we will discuss
about the importance of individualizing therapy.</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://elea.unisa.it/xmlui/handle/10556/627</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

